Antonio Lamb

Antonio is a Microbiology and Immunology PhD student at the University of Zurich, where he works on developing in vivo and in vitro experimental systems to model host-pathogen interactions of the skin fungus, malassezia. After completing his undergraduate degree at the University of California, Santa Cruz, he completed his M.Sc. in molecular biology at the University of Basel. While there, he studied the virulence program of the opportunistic pathogen, Pseudomonas aeruginosa using live lung cell infection fluorescence microscopy. Antonio also cofounded MicroSynbiotiX, an algal synthetic biology startup developing oral vaccines and RNAi therapeutics for the aquatic animal health industry, which was later acquired. Antonio also worked briefly as a scientist at Novartis, where he conducted CRISPR genetic screening of advanced 3D cell culture models for drug discovery.

Sign up now

Want to stay up to date? Sign up for our newsletter

No, thanks